Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy

MRC HIU NDCN

The paper, published in Nature Communications reveals key genes involved in the common developmental disease.

Seven research groups secure LEAF Sustainability Awards

Department of Oncology MRC HIU MRC MHU NDCN RDM

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Spatial transcriptomics of neurodegeneration in Progressive Multiple Sclerosis (MS)

MRC HIU NDCN

In a paper published in Nature Neuroscience, the Fugger Group describe molecular pathways of MS neurodegeneration in unprecedented detail.

Funding awarded for autoimmune disease research

MRC HIU NDCN

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

NDCN

MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.

Angela Vincent honoured for excellence in epilepsy research

NDCN

Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.

New research to investigate role of blood-brain barrier

NDCN

A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.

European licence for migraine prevention drug

NDCN

MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines

World’s largest autism grant will transform research landscape

NDCN

The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.

Oxford Centre for Neuroinflammation launched

MRC HIU NDCN

The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.

Prof David Beeson elected Fellow of the Academy of Medical Sciences

NDCN

Many congratulations to Prof Beeson for this distinction recognising his exceptional contribution to the study of neuromuscular disorders.

MRC WIMM researchers talk about their research on rare diseases

Department of Oncology MRC MHU NDCN RDM

To mark rare disease day we asked our researchers to tell us more about the rare conditions that they study, and why their research is important.